KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Elanco Animal Health (ELAN) Restructuring Costs (2017 - 2023)

Historic Restructuring Costs for Elanco Animal Health (ELAN) over the last 7 years, with Q2 2023 value amounting to $35.0 million.

  • Elanco Animal Health's Restructuring Costs fell 5930.23% to $35.0 million in Q2 2023 from the same period last year, while for Jun 2023 it was $126.0 million, marking a year-over-year decrease of 6430.59%. This contributed to the annual value of $183.0 million for FY2022, which is 7113.56% down from last year.
  • As of Q2 2023, Elanco Animal Health's Restructuring Costs stood at $35.0 million, which was down 5930.23% from $40.0 million recorded in Q1 2023.
  • In the past 5 years, Elanco Animal Health's Restructuring Costs ranged from a high of $305.0 million in Q2 2021 and a low of $24.9 million during Q1 2019
  • Moreover, its 5-year median value for Restructuring Costs was $76.1 million (2019), whereas its average is $94.5 million.
  • As far as peak fluctuations go, Elanco Animal Health's Restructuring Costs soared by 93750.0% in 2019, and later tumbled by 7844.83% in 2022.
  • Elanco Animal Health's Restructuring Costs (Quarter) stood at $51.6 million in 2019, then skyrocketed by 224.22% to $167.3 million in 2020, then tumbled by 30.66% to $116.0 million in 2021, then crashed by 78.45% to $25.0 million in 2022, then soared by 40.0% to $35.0 million in 2023.
  • Its Restructuring Costs was $35.0 million in Q2 2023, compared to $40.0 million in Q1 2023 and $25.0 million in Q4 2022.